Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Amphastar Nanjing Pharmaceuticals Inc
FDA Inspection
•Amphastar Nanjing Pharmaceuticals Inc•September 19, 2025

Amphastar Nanjing Pharmaceuticals Inc – FDA Inspection, Sep 19, 2025

Record Details

This FDA Inspection record concerns Amphastar Nanjing Pharmaceuticals Inc, with an inspection on September 19, 2025, issued by the Office of Inspections and Investigations, covering human drugs.

Company
Amphastar Nanjing Pharmaceuticals Inc
Inspection Date
September 19, 2025
Product Type
Human Drugs
Office
Office of Inspections and Investigations
People
  • Doan N. Singh (Issuing Officer)
  • Duan Singh (Issuing Officer)
  • Tamanna Azam (Issuing Officer)
  • Xiaoshi Wang
View Company Profile

ID · 8c11e7e8-9c3d-43fb-940f-6748a59595b1

Inspection Facts

Inspection number
1291882
FDA center
Human Drugs
Outcome
Form 483 issued, view the record

Other FDA inspections of Amphastar Nanjing Pharmaceuticals Inc

6
DateClassificationOfficeProject area
March 7, 2025Not classifiedOffice of Inspections and Investigations
October 11, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
October 26, 2017NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
April 28, 2017Not classifiedOffice of Inspections and Investigations
April 29, 2016NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 6 other inspections on the company page
Other documents for Amphastar Nanjing Pharmaceuticals Inc
  • FDA Inspection 1269036 - 2025-03-07
  • FDA Inspection 1107981 - 2019-10-11
  • FDA Inspection 1036696 - 2017-10-26
  • FDA Inspection 1017547 - 2017-04-28
  • FDA Inspection 969870 - 2016-04-29

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Amphastar Nanjing Pharmaceuticals Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.